HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-111 and U-101033E.

Abstract
We recently demonstrated that posttraumatic administration of the N-type calcium channel blocker SNX-111 (S) and a novel blood-brain barrier penetrating antioxidant U-101033E (U), significantly alleviated mitochondrial dysfunction induced by traumatic brain injury (TBI) in rats. The present study was designed to determine whether a combination of S and U, which act on different biochemical mechanisms of secondary brain injury, would be more efficacious than either drug alone. Brain mitochondria from injured and uninjured hemispheres were isolated and examined at 12 h post TBI induced by a severe controlled cortical impact injury. S at 1.0 mg/kg significantly increased both State 3 and 4 rates and produced a slight increase in P/O ratio, and there was virtually no change in RCI. U at 1.0 mg/kg did not show any protection. However, the combined treatment of S at 1.0 mg/kg and U at 1.0 mg/kg eliminated the uncoupling effect of S, and restored not only State 3 rates and P/O ratios but also RCI to near sham values. These results provide further evidence that both reactive oxygen species and perturbation of cellular calcium homeostasis participate in the pathogenesis of TBI-induced mitochondrial dysfunction, and support the idea of using combined therapy with lower drug doses.
AuthorsY Xiong, P L Peterson, B H Verweij, F C Vinas, J P Muizelaar, C P Lee
JournalJournal of neurotrauma (J Neurotrauma) Vol. 15 Issue 7 Pg. 531-44 (Jul 1998) ISSN: 0897-7151 [Print] United States
PMID9674556 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Calcium Channel Blockers
  • Neuroprotective Agents
  • Peptides
  • Pyrimidines
  • Pyrrolidines
  • U 101033E
  • omega-Conotoxins
  • ziconotide
  • Calcium-Transporting ATPases
  • Calcium
Topics
  • Analysis of Variance
  • Animals
  • Antioxidants (pharmacology)
  • Brain Injuries (drug therapy, prevention & control)
  • Calcium (metabolism)
  • Calcium Channel Blockers (pharmacology)
  • Calcium-Transporting ATPases (drug effects)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Electron Transport (drug effects)
  • Male
  • Mitochondria (drug effects, physiology)
  • Neuroprotective Agents (pharmacology)
  • Oxidative Phosphorylation (drug effects)
  • Peptides (pharmacology)
  • Pyrimidines (pharmacology)
  • Pyrrolidines (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • omega-Conotoxins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: